ArticleFrontiers in oncology2023

Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.

Hideki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.